Suppression of protein kinase RNA-like endoplasmic reticulum kinase by probiotics circumvents cardiovascular risk profile in experimentally induced PCOS model
Canadian Journal of Physiology and Pharmacology · 2025
DOI: 10.1139/cjpp-2025-0095 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Journal of Physiology and Pharmacology, 2025. Verfasst von Esosa Stephanie Areloegbe und 2 weiteren Autor:innen. Beteiligte Einrichtung: Cardio/Endo-metabolic and Microbiome Research Unit, Department of Physiology, College of Medicine and Health Sciences, Afe Babalola University, Ado-E…. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Probiotics, eIF-2 Kinase, Cardiovascular Diseases. Die Arbeit nennt 54 Literaturangaben.
Abstract (Originalsprache)
The present study was designed to investigate the role of PERK in CVD risk associated with polycystic ovarian syndrome (PCOS) in experimental rat model, and the therapeutic benefits of probiotics. Eight-weeks-old female Wistar rats were assigned into four groups ( n = 6): Control (CTRL), Probiotics (PROB), Letrozole (PCOS), and PCOS + PROB. Daily administration of letrozole (1 mg/kg) for 21 days was used to induce PCOS; thereafter, probiotics (3 × 10 9 CFU) was administered daily for 6 weeks. Biochemical parameters and histological evaluations were performed with appropriate techniques. The present findings revealed that animals with PCOS were characterized with phenotypic features such as hyperandrogenemia and multiple cysts in the ovaries. In addition, PCOS rats manifested insulin resistance and increase in glucose regulatory protein (GRP78), together with increased levels of circulating corticosterone, cardiac triglyceride, inflammatory mediators (NF-κB and TNF-α), TGF-β1, Caspase-6, and HDAC2, while a decrease in HIF-1α and NrF2 was observed when compared with control animals. These were accompanied by elevated level of PERK. However, treatment with probiotics reversed these systemic, endocrine, metabolic, and cardiac anomalies. The present study suggests that probiotics attenuates CVD risk profile in experimental PCOS rat model by suppression of PERK/HDAC2-dependent pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardio/Endo-metabolic and Microbiome Research Unit, Department of Physiology, College of Medicine and Health Sciences, Afe Babalola University, Ado-Ekiti 360101, Nigeria.
- Department of Human Anatomy, College of Medicine and Health Sciences, Afe Babalola University, Ado-Ekiti 360101, Nigeria.
ORCID-Profile: Samuel Kehinde Olaniyi
Zitieren
APA
Areloegbe, E., Enye, A., & Olaniyi, S. K. (2025). Suppression of protein kinase RNA-like endoplasmic reticulum kinase by probiotics circumvents cardiovascular risk profile in experimentally induced PCOS model. Canadian Journal of Physiology and Pharmacology. https://doi.org/10.1139/cjpp-2025-0095
Vancouver
Areloegbe E, Enye A, Olaniyi SK. Suppression of protein kinase RNA-like endoplasmic reticulum kinase by probiotics circumvents cardiovascular risk profile in experimentally induced PCOS model. Canadian Journal of Physiology and Pharmacology. 2025. doi:10.1139/cjpp-2025-0095
BibTeX
@article{Areloegbe2025,
author = {Areloegbe, Esosa Stephanie and Enye, Anderson Linus and Olaniyi, Samuel Kehinde},
title = {Suppression of protein kinase RNA-like endoplasmic reticulum kinase by probiotics circumvents cardiovascular risk profile in experimentally induced PCOS model},
journal = {Canadian Journal of Physiology and Pharmacology},
year = {2025},
doi = {10.1139/cjpp-2025-0095}
}
EUVIMED